Skip to content
10-Q

Quarterly Report

VIELA BIO, INC.

0001564590-20-039712

← back to feed
Filed
Aug 12, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2020 · Aug 12, 2020 54.72M sh
Capex Q2 2020 · Jun 30, 2020 $296K
Capex Q2 2020 · Jun 30, 2019 $60K
Operating Cash Flow Q2 2020 · Jun 30, 2020 −$57.56M
Operating Cash Flow Q2 2020 · Jun 30, 2019 −$25.66M
Cash And Equivalents Q2 2020 · Jun 30, 2020 $131.55M
Cash And Equivalents Q2 2020 · Dec 31, 2019 $200.85M
Stockholders Equity Q2 2020 · Jun 30, 2020 $440.22M
Stockholders Equity Q2 2020 · Mar 31, 2020 $316.42M
Stockholders Equity Q2 2020 · Dec 31, 2019 $354.51M
Stockholders Equity Q2 2020 · Jun 30, 2019 −$212.53M
Stockholders Equity Q2 2020 · Mar 31, 2019 −$208.73M
Stockholders Equity Q2 2020 · Dec 31, 2018 −$188.39M
Current Liabilities Q2 2020 · Jun 30, 2020 $40.94M
Current Liabilities Q2 2020 · Dec 31, 2019 $29.54M
Total Liabilities Q2 2020 · Jun 30, 2020 $41.78M
Total Liabilities Q2 2020 · Dec 31, 2019 $29.54M
Current Assets Q2 2020 · Jun 30, 2020 $436.81M
Current Assets Q2 2020 · Dec 31, 2019 $351.04M
Total Assets Q2 2020 · Jun 30, 2020 $482M
Total Assets Q2 2020 · Dec 31, 2019 $384.05M
Net Income Q2 2020 · Jun 30, 2020 −$38.86M
Net Income Q2 2020 · Jun 30, 2020 −$79.63M
Net Income Q2 2020 · Jun 30, 2019 −$5.47M
Net Income Q2 2020 · Jun 30, 2019 −$26.45M
Operating Income Q2 2020 · Jun 30, 2020 −$39.82M
Operating Income Q2 2020 · Jun 30, 2020 −$81.93M
Operating Income Q2 2020 · Jun 30, 2019 −$6.11M
Operating Income Q2 2020 · Jun 30, 2019 −$27.76M
Revenue Q2 2020 · Jun 30, 2019 $20M
Revenue Q2 2020 · Jun 30, 2019 $20M